Published in Cancer Weekly, February 15th, 1999
A.I. Chapoval and colleagues from the Mayo Clinic, Minnesota, investigated the pathogenesis responsible for tumor regression as a result of combination therapy in a murine model ("Combination Chemotherapy and IL-15 Administration Induce Permanent Tumor Regression in a Mouse Lung Tumor Model: NK and T Cell-Mediated Effects Antagonized by B Cells," Journal of Immunology, December 15, 1998;161(12):6977-6984).
"Previous studies have demonstrated that IL-15 administration after cyclophosphamide (CY) injection of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.